ESR1 and neoplasm: The different TP53 RNA transcripts play distinct biological roles and in breast cancer, the TP53β 3′ end levels have been negatively associated with tumor size, and positively associated with estrogen receptor (ER) positive tumors and better patient outcomes [14,15].